
Findings from 2 phase 3 trials indicate that ZORYVE cream significantly improves both clinical outcomes and quality of life in patients with mild to moderate atopic dermatitis.

Findings from 2 phase 3 trials indicate that ZORYVE cream significantly improves both clinical outcomes and quality of life in patients with mild to moderate atopic dermatitis.

Andrew F. Alexis, MD, MPH, shared insights into using JAK inhibitors as part of the treatment revolution in atopic dermatitis at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Atoosa Kourosh, MD, MPH, delves into opportunities for allergists and dermatologists to collaborate, her approach to cases, and patient resources.

Ama Alexis, MD, shared the importance of recognizing diverse presentations of atopic dermatitis at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Session at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.

Marcella R. Aquino details issues in differential diagnosis for rashes that mimic allergic skin conditions at the ACAAI Annual Meeting.

Karen S. Hsu Blatman, MD, shared key insights on biologics at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Kamran H. Imam, MD, hopes to unlock insights into the atopic disease burden among Native American populations.

Late-breaking data adds important safety and efficacy data for leukotriene receptor antagonists augmentation in chronic urticaria treatment.


What are some of the challenges and triumphs in using biologics for atopic dermatitis? Abby L. Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting.

The second full day of the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting was filled with new data, important insights, and more.

Research at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting discusses the impact of an educational program on improving care.

Todd L. Sack, MD, shares practice management tips for going green at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Poster presented at American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting yields positive results for adults and children 2 years age and up.

Amanda L. Michaud, PA-C, shares insights on difficult to control chronic spontaneous urticaria at the ACAAI Annual Scientific Meeting.

Catch up on highlights from the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Ruchi Gupta, MD, MPH, shares tips for supporting a successful transition to college for patients with atopic dermatitis.

Program Chair Jay A. Lieberman, MD, provides a glimpse into the clinical pearls and dermatological educational opportunities presented at the ACAAI 2023 Annual Scientific Meeting.

A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis.

Data from Novartis will be presented at the 2023 American College of Allergy, Asthma, and Immunology Scientific Meeting.

New treatments and clinical insights will be shared at this year's American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

Factors ranging from demographics to the COVID-19 pandemic are shifting the landscape of occupational dermatoses.

In this video interview, Fatima Khan, MD, discusses how atopic dermatitis can be detrimental to pediatric patients sleep, how the condition can change as the patient gets older, and more.

In a session at ACAAI’s Annual Scientific Meeting, David R. Weldon, MD, FACAAI, FAAAI, demonstrates punch biopsies for allergists and discusses the importance of knowing when to collaborate with dermatologists.

Patch testing can prove very useful in patients with suspected sensitization to a variety of allergens contained in personal care products and orthopedic implants.

Helen Brough, MA, MSc, PhD, MBBS, FAAAAI, FRCPCH, discusses the role of AD skin in infants and emollient application for preventing food allergy.

In this video interview, Mark Serota, MD, highlights the key talking points from his session at the 2021 ACAAI annual scientific meeting.

Involving patients with atopic dermatitis in decisions about developing their treatment plan can lead to improved treatment outcomes and higher satisfaction, the American College of Allergy, Asthma & Immunology (ACAAI) medical director said in a luncheon presentation at the college’s 2021 Annual Scientific Symposium.

In this video interview, Jeff Yu, MD, highlights key talking points from his session on regional dermatitis and rash from the American College of Allergy, Asthma & Immunology annual scientific meeting.